X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
37
PharmaCompass offers a list of Docetaxel API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Docetaxel manufacturer or Docetaxel supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Docetaxel manufacturer or Docetaxel supplier.
PharmaCompass also assists you with knowing the Docetaxel API Price utilized in the formulation of products. Docetaxel API Price is not always fixed or binding as the Docetaxel Price is obtained through a variety of data sources. The Docetaxel Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A docetaxel anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of docetaxel anhydrous, including repackagers and relabelers. The FDA regulates docetaxel anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. docetaxel anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of docetaxel anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A docetaxel anhydrous supplier is an individual or a company that provides docetaxel anhydrous active pharmaceutical ingredient (API) or docetaxel anhydrous finished formulations upon request. The docetaxel anhydrous suppliers may include docetaxel anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of docetaxel anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A docetaxel anhydrous DMF (Drug Master File) is a document detailing the whole manufacturing process of docetaxel anhydrous active pharmaceutical ingredient (API) in detail. Different forms of docetaxel anhydrous DMFs exist exist since differing nations have different regulations, such as docetaxel anhydrous USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A docetaxel anhydrous DMF submitted to regulatory agencies in the US is known as a USDMF. docetaxel anhydrous USDMF includes data on docetaxel anhydrous's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The docetaxel anhydrous USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of docetaxel anhydrous suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The docetaxel anhydrous Drug Master File in Japan (docetaxel anhydrous JDMF) empowers docetaxel anhydrous API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the docetaxel anhydrous JDMF during the approval evaluation for pharmaceutical products. At the time of docetaxel anhydrous JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of docetaxel anhydrous suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a docetaxel anhydrous Drug Master File in Korea (docetaxel anhydrous KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of docetaxel anhydrous. The MFDS reviews the docetaxel anhydrous KDMF as part of the drug registration process and uses the information provided in the docetaxel anhydrous KDMF to evaluate the safety and efficacy of the drug.
After submitting a docetaxel anhydrous KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their docetaxel anhydrous API can apply through the Korea Drug Master File (KDMF).
click here to find a list of docetaxel anhydrous suppliers with KDMF on PharmaCompass.
A docetaxel anhydrous CEP of the European Pharmacopoeia monograph is often referred to as a docetaxel anhydrous Certificate of Suitability (COS). The purpose of a docetaxel anhydrous CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of docetaxel anhydrous EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of docetaxel anhydrous to their clients by showing that a docetaxel anhydrous CEP has been issued for it. The manufacturer submits a docetaxel anhydrous CEP (COS) as part of the market authorization procedure, and it takes on the role of a docetaxel anhydrous CEP holder for the record. Additionally, the data presented in the docetaxel anhydrous CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the docetaxel anhydrous DMF.
A docetaxel anhydrous CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. docetaxel anhydrous CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of docetaxel anhydrous suppliers with CEP (COS) on PharmaCompass.
A docetaxel anhydrous written confirmation (docetaxel anhydrous WC) is an official document issued by a regulatory agency to a docetaxel anhydrous manufacturer, verifying that the manufacturing facility of a docetaxel anhydrous active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting docetaxel anhydrous APIs or docetaxel anhydrous finished pharmaceutical products to another nation, regulatory agencies frequently require a docetaxel anhydrous WC (written confirmation) as part of the regulatory process.
click here to find a list of docetaxel anhydrous suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing docetaxel anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for docetaxel anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture docetaxel anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain docetaxel anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a docetaxel anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of docetaxel anhydrous suppliers with NDC on PharmaCompass.
docetaxel anhydrous Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of docetaxel anhydrous GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right docetaxel anhydrous GMP manufacturer or docetaxel anhydrous GMP API supplier for your needs.
A docetaxel anhydrous CoA (Certificate of Analysis) is a formal document that attests to docetaxel anhydrous's compliance with docetaxel anhydrous specifications and serves as a tool for batch-level quality control.
docetaxel anhydrous CoA mostly includes findings from lab analyses of a specific batch. For each docetaxel anhydrous CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
docetaxel anhydrous may be tested according to a variety of international standards, such as European Pharmacopoeia (docetaxel anhydrous EP), docetaxel anhydrous JP (Japanese Pharmacopeia) and the US Pharmacopoeia (docetaxel anhydrous USP).
Market Place
